Astera Labs (NASDAQ:ALAB) Stock Price Down 9.7% – What’s Next?

Shares of Astera Labs, Inc. (NASDAQ:ALAB) traded down 9.7% on Tuesday . The stock traded as low as $392.89 and last traded at $397.02. Approximately 6,455,858 shares were traded during mid-day trading, an increase of 13% from the average daily volume of 5,711,881 shares. The stock had previously closed at $439.66.

Wall Street Analyst Weigh In

ALAB has been the subject of several analyst reports. Stifel Nicolaus upped their price target on Astera Labs from $236.00 to $260.00 and gave the stock a “buy” rating in a research note on Wednesday, May 6th. Evercore reiterated an “outperform” rating and issued a $297.00 price objective on shares of Astera Labs in a research report on Tuesday, May 19th. Susquehanna upped their price objective on shares of Astera Labs from $155.00 to $230.00 and gave the stock a “neutral” rating in a research report on Wednesday, May 6th. Jefferies Financial Group restated a “buy” rating and issued a $270.00 target price on shares of Astera Labs in a research note on Wednesday, May 6th. Finally, Morgan Stanley lifted their target price on shares of Astera Labs from $210.00 to $240.00 and gave the company an “overweight” rating in a report on Wednesday, May 6th. Twelve research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company. According to data from MarketBeat.com, Astera Labs has a consensus rating of “Moderate Buy” and an average price target of $244.75.

Astera Labs Price Performance

The company has a 50-day simple moving average of $270.63 and a 200-day simple moving average of $189.58. The stock has a market cap of $68.05 billion, a PE ratio of 268.26, a PEG ratio of 5.52 and a beta of 3.95.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, topping analysts’ consensus estimates of $0.54 by $0.07. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The firm had revenue of $308.36 million for the quarter, compared to the consensus estimate of $292.19 million. During the same quarter in the previous year, the firm earned $0.33 earnings per share. The firm’s revenue was up 93.5% on a year-over-year basis. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, equities analysts expect that Astera Labs, Inc. will post 1.84 EPS for the current fiscal year.

Insider Activity at Astera Labs

In other news, COO Sanjay Gajendra sold 400,000 shares of the firm’s stock in a transaction on Thursday, May 21st. The stock was sold at an average price of $290.30, for a total value of $116,120,000.00. Following the completion of the transaction, the chief operating officer owned 5,064,213 shares in the company, valued at $1,470,141,033.90. This trade represents a 7.32% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan A. Dyckerhoff sold 3,505 shares of the firm’s stock in a transaction dated Wednesday, June 3rd. The shares were sold at an average price of $364.35, for a total transaction of $1,277,046.75. Following the transaction, the director owned 60,134 shares of the company’s stock, valued at $21,909,822.90. This trade represents a 5.51% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 2,161,256 shares of company stock valued at $459,844,296 in the last 90 days. 10.40% of the stock is owned by corporate insiders.

Institutional Trading of Astera Labs

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Empowered Funds LLC lifted its holdings in Astera Labs by 5.1% in the 1st quarter. Empowered Funds LLC now owns 9,606 shares of the company’s stock valued at $1,053,000 after purchasing an additional 462 shares in the last quarter. Carmignac Gestion purchased a new stake in shares of Astera Labs during the first quarter worth about $6,576,000. Shariaportfolio Inc. acquired a new position in shares of Astera Labs in the first quarter valued at approximately $5,304,000. Glenmede Trust Co. NA raised its position in shares of Astera Labs by 2.7% in the first quarter. Glenmede Trust Co. NA now owns 1,909 shares of the company’s stock valued at $209,000 after buying an additional 51 shares during the last quarter. Finally, Verus Capital Partners LLC lifted its stake in shares of Astera Labs by 16.4% during the first quarter. Verus Capital Partners LLC now owns 3,849 shares of the company’s stock valued at $422,000 after buying an additional 541 shares during the period. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.